Rosenberg Ellen
Chief Legal Officer
Rosenberg Ellen has filed 3 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Apr 27, 2026.
On the most recent filing, Rosenberg Ellen is listed as Chief Legal Officer at AMICUS THERAPEUTICS, INC. Inside the rolling window, Rosenberg Ellen reported no open-market purchases and 3 open-market sales totaling $958K in FOLD. The largest disclosed transaction in the window is a sale of 36,000 FOLD shares on Nov 24, 2025, worth $362K.
Companies traded
Other insiders at FOLD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$958K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rosenberg Ellen made?
Rosenberg Ellen has filed 3 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Rosenberg Ellen trade?
Rosenberg Ellen has filed SEC Form 4 disclosures for 1 company, including FOLD.
When was Rosenberg Ellen's most recent SEC Form 4 filing?
Rosenberg Ellen's most recent SEC Form 4 filing on Tracefour is dated Apr 27, 2026.
What is Rosenberg Ellen's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rosenberg Ellen is listed as Chief Legal Officer.
What is Rosenberg Ellen's total buy and sell value in the current window?
Inside the rolling retention window, Rosenberg Ellen bought $0 and sold $958K based on SEC Form 4 filings.
What was Rosenberg Ellen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 36,000 FOLD shares on 2025-11-24, worth $362K, per SEC Form 4 filings.